Healthcare · Q2FY27 · Standalone

Vineet Labs revenue jumps, but tax charge cuts profit by 92%

Expenses outpaced revenue growth and the tax rate swung sharply, while operating margin remained below the healthcare peer median.

By Ashutosh

Filed 13 Nov 2026, 13:21 IST · Vineet Laboratories Ltd (VINEETLAB)

Key takeaways

  • Standalone revenue rose 36.48% sequentially to Rs 14.18 cr, but expenses grew faster at 45.70%, cutting operating margin by 5.30 percentage points.
  • Net profit fell 92.05% sequentially to Rs 0.12 cr as the tax rate swung from -92.73% to 91.69%, despite a 75.95% rise in profit before tax.
  • Operating margin at 16.36% was 5.28 percentage points below the 21.64% median for 103 reported healthcare peers.

Price around the results

Revenue recovered, but costs grew faster

Standalone revenue increased 36.48% sequentially to Rs 14.18 cr, while operating profit rose only 3.11% to Rs 2.32 cr. Expenses grew 45.70%, outpacing revenue growth and reducing operating margin to 16.36% from 21.66% in Q1FY27. Depreciation was unchanged at Rs 0.60 cr, while interest expense fell 64.95% to Rs 0.34 cr.

Tax swing overwhelmed the pre-tax improvement

Profit before tax rose 75.95% sequentially to Rs 1.39 cr, but the tax rate moved up 184.42 percentage points to 91.69% from a negative 92.73% in the previous quarter. That tax charge reduced net profit by 92.05% to Rs 0.12 cr and EPS to Rs 0.06. Other income contributed only 1.44% of pre-tax profit, so it was not a material support for earnings quality.

Margin remains below peers after a one-quarter rebound

Operating margin improved from 13.21% in Q4FY26 to 21.66% in Q1FY27 before falling to 16.36% in Q2FY27, so the latest quarter marks a sequential reversal rather than a third straight decline. The margin was 5.28 percentage points below the 21.64% median of 103 healthcare companies that had reported.

Initial stock reaction was limited

The stock opened 1.64% higher but was down 0.32% at the measured reaction point, with relative performance of 0.30%. Trading volume was 0.32 times the reference level.

Q2FY27 at a glance

Standalone figures as filed with NSE — filed ahead of third-party databases, not yet independently cross-checked.

Line itemQ2FY27Q1FY27QoQ
Revenue₹14 cr₹10 cr+36.48%
Other income₹0 cr₹0 cr-81.82%
Expenses₹12 cr₹8 cr+45.70%
Operating profit₹2 cr₹2 cr+3.11%
Operating margin (%)16.36%21.66%—
Interest₹0 cr₹1 cr-64.95%
Depreciation₹1 cr₹1 cr+0.00%
Profit before tax₹1 cr₹1 cr+75.95%
Tax₹1 cr₹-1 cr—
Net profit₹0 cr₹2 cr-92.05%
EPS (₹)₹0.06₹0.73-91.78%

Operating margin of 16.36% compares with a Healthcare sector median of 21.64% across 103 peers that have reported Q2FY27.

How the stock reacted

WindowStockvs NIFTY
Results day-0.32%+0.30%

Volume on the results session was 0.32× its 20-day average.

What to watch

  • Whether operating margin recovers from 16.36% after the 5.30-percentage-point sequential decline.
  • Whether the tax rate moves down from 91.69% after the 184.42-percentage-point sequential swing.
  • Whether expenses continue to grow faster than revenue after rising 45.70% versus revenue growth of 36.48%.